- Home
- PMD vs PMCB Comparison
PMD vs PMCB Comparison
Compare PMD & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMD
- PMCB
- Stock Information
- Founded
- PMD 1986
- PMCB 1996
- Country
- PMD United States
- PMCB United States
- Employees
- PMD N/A
- PMCB N/A
- Industry
- PMD Medical Specialities
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMD Health Care
- PMCB Health Care
- Exchange
- PMD Nasdaq
- PMCB Nasdaq
- Market Cap
- PMD 13.3M
- PMCB 15.8M
- IPO Year
- PMD N/A
- PMCB N/A
- Fundamental
- Price
- PMD $2.32
- PMCB $1.92
- Analyst Decision
- PMD
- PMCB
- Analyst Count
- PMD 0
- PMCB 0
- Target Price
- PMD N/A
- PMCB N/A
- AVG Volume (30 Days)
- PMD 37.5K
- PMCB 18.6K
- Earning Date
- PMD 11-07-2024
- PMCB 09-27-2024
- Dividend Yield
- PMD N/A
- PMCB N/A
- EPS Growth
- PMD N/A
- PMCB N/A
- EPS
- PMD N/A
- PMCB N/A
- Revenue
- PMD $20,787,000.00
- PMCB N/A
- Revenue This Year
- PMD N/A
- PMCB N/A
- Revenue Next Year
- PMD N/A
- PMCB N/A
- P/E Ratio
- PMD N/A
- PMCB N/A
- Revenue Growth
- PMD N/A
- PMCB N/A
- 52 Week Low
- PMD $1.63
- PMCB $1.39
- 52 Week High
- PMD $4.04
- PMCB $2.61
- Technical
- Relative Strength Index (RSI)
- PMD 57.36
- PMCB 59.56
- Support Level
- PMD $2.27
- PMCB $1.45
- Resistance Level
- PMD $2.31
- PMCB $1.77
- Average True Range (ATR)
- PMD 0.02
- PMCB 0.16
- MACD
- PMD 0.00
- PMCB 0.05
- Stochastic Oscillator
- PMD 91.67
- PMCB 83.61
About PMD Psychemedics Corporation
Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. They provide testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples. Geographically it generates the majority of its revenue from the United States.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.